Margulis leaves MMI Medical

Article

MMI Medical president and CEO Alan Margulis has left the Corona, CA, company, which is the parentof independent service organization InnoServ Technologies. Margulisand MMI's board parted ways several days after MMI posted financialresults for the third

MMI Medical president and CEO Alan Margulis has left the Corona, CA, company, which is the parentof independent service organization InnoServ Technologies. Margulisand MMI's board parted ways several days after MMI posted financialresults for the third quarter of fiscal 1995 (end-January). MMIcofounder Dr. Samuel Salen was tapped as interim president andCEO until a replacement for Margulis is found.

MMI announced Margulis' departure on March 13, a few days afterit reported quarterly numbers that showed revenue up but incomedown. Sales for the quarter were $10.6 million, compared to $7.8million in the third quarter of fiscal 1994. The company had netincome for the quarter of $121,000, which halted a streak of twoconsecutive losing quarters. Net income was $421,000 in the sameperiod the year before. MMI had a net loss of $1 million for itsfirst nine months of 1995, against a net gain of $1.5 millionat the same point in 1994.

MMI bought Mediq Equipment and Maintenance Services (MEMS)last year, merged it into its R Squared subsidiary and renamedthe new ISO InnoServ (SCAN 10/12/94 and 6/1/94).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.